214 related articles for article (PubMed ID: 16487009)
1. PTEN promoter methylation in sporadic thyroid carcinomas.
Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
[TBL] [Abstract][Full Text] [Related]
2. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Dahia PL; Marsh DJ; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Cancer Res; 1997 Nov; 57(21):4710-3. PubMed ID: 9354427
[TBL] [Abstract][Full Text] [Related]
3. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
5. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
Hou P; Ji M; Xing M
Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors.
Halachmi N; Halachmi S; Evron E; Cairns P; Okami K; Saji M; Westra WH; Zeiger MA; Jen J; Sidransky D
Genes Chromosomes Cancer; 1998 Nov; 23(3):239-43. PubMed ID: 9790504
[TBL] [Abstract][Full Text] [Related]
7. Considerations when analyzing the methylation status of PTEN tumor suppressor gene.
Zysman MA; Chapman WB; Bapat B
Am J Pathol; 2002 Mar; 160(3):795-800. PubMed ID: 11891178
[TBL] [Abstract][Full Text] [Related]
8. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis.
Boltze C; Zack S; Quednow C; Bettge S; Roessner A; Schneider-Stock R
Pathol Res Pract; 2003; 199(6):399-404. PubMed ID: 12924440
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
[TBL] [Abstract][Full Text] [Related]
11. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
Gimm O; Perren A; Weng LP; Marsh DJ; Yeh JJ; Ziebold U; Gil E; Hinze R; Delbridge L; Lees JA; Mutter GL; Robinson BG; Komminoth P; Dralle H; Eng C
Am J Pathol; 2000 May; 156(5):1693-700. PubMed ID: 10793080
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
[TBL] [Abstract][Full Text] [Related]
13. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
14. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors.
Eng C
Recent Prog Horm Res; 1999; 54():441-52; discussion 453. PubMed ID: 10548886
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
16. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of the PTEN gene is a common molecular change in breast cancer.
García JM; Silva J; Peña C; Garcia V; Rodríguez R; Cruz MA; Cantos B; Provencio M; España P; Bonilla F
Genes Chromosomes Cancer; 2004 Oct; 41(2):117-24. PubMed ID: 15287024
[TBL] [Abstract][Full Text] [Related]
18. PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
Beg S; Siraj AK; Jehan Z; Prabakaran S; Al-Sobhi SS; Al-Dawish M; Al-Dayel F; Al-Kuraya KS
Br J Cancer; 2015 Jun; 112(12):1938-43. PubMed ID: 25989274
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
20. Altered transcription and expression of PTEN in breast tumors: is it regulated by hypermethylation?
Shetty PJ; Pasupuleti N; Chava S; Nasaruddin K; Hasan Q
Breast Dis; 2011; 33(1):27-33. PubMed ID: 21846942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
